State of Wisconsin Investment Board’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-119,987
| Closed | -$571K | – | 2535 |
|
|
2023
Q2 | $571K | Sell |
119,987
-67,398
| -36% | -$321K | ﹤0.01% | 1756 |
|
|
2023
Q1 | $1.07M | Buy |
187,385
+92,779
| +98% | +$529K | ﹤0.01% | 1452 |
|
|
2022
Q4 | $955K | Buy |
94,606
+15,689
| +20% | +$158K | ﹤0.01% | 1520 |
|
|
2022
Q3 | $1.77M | Sell |
78,917
-3,870
| -5% | -$86.8K | 0.01% | 1369 |
|
|
2022
Q2 | $2.05M | Sell |
82,787
-25,913
| -24% | -$642K | 0.01% | 1355 |
|
|
2022
Q1 | $4.21M | Hold |
108,700
| – | – | 0.01% | 1224 |
|
|
2021
Q4 | $6.36M | Buy |
108,700
+6,200
| +6% | +$363K | 0.01% | 952 |
|
|
2021
Q3 | $6.08M | Sell |
102,500
-3,829
| -4% | -$227K | 0.01% | 969 |
|
|
2021
Q2 | $9.23M | Sell |
106,329
-271
| -0.3% | -$23.5K | 0.02% | 799 |
|
|
2021
Q1 | $8.79M | Buy |
106,600
+2,500
| +2% | +$206K | 0.02% | 796 |
|
|
2020
Q4 | $9.47M | Buy |
104,100
+3,600
| +4% | +$327K | 0.02% | 693 |
|
|
2020
Q3 | $4.02M | Hold |
100,500
| – | – | 0.01% | 993 |
|
|
2020
Q2 | $3.45M | Buy |
100,500
+6,900
| +7% | +$237K | 0.01% | 992 |
|
|
2020
Q1 | $2.08M | Buy |
93,600
+4,600
| +5% | +$102K | 0.01% | 1053 |
|
|
2019
Q4 | $1.74M | Hold |
89,000
| – | – | ﹤0.01% | 1146 |
|
|
2019
Q3 | $1.38M | Hold |
89,000
| – | – | ﹤0.01% | 1078 |
|
|
2019
Q2 | $1.81M | Buy |
89,000
+2,000
| +2% | +$40.6K | 0.01% | 1036 |
|
|
2019
Q1 | $1.53M | Buy |
87,000
+35,100
| +68% | +$617K | ﹤0.01% | 1051 |
|
|
2018
Q4 | $666K | Buy |
51,900
+1,300
| +3% | +$16.7K | ﹤0.01% | 1245 |
|
|
2018
Q3 | $824K | Hold |
50,600
| – | – | ﹤0.01% | 1272 |
|
|
2018
Q2 | $574K | Buy |
50,600
+20,600
| +69% | +$234K | ﹤0.01% | 1327 |
|
|
2018
Q1 | $293K | Hold |
30,000
| – | – | ﹤0.01% | 1367 |
|
|
2017
Q4 | $183K | Hold |
30,000
| – | – | ﹤0.01% | 1392 |
|
|
2017
Q3 | $119K | Hold |
30,000
| – | – | ﹤0.01% | 1431 |
|
|
2017
Q2 | $97K | Buy |
+30,000
| New | +$97K | ﹤0.01% | 1446 |
|